ABT: Abbott Laboratories Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ABT: Abbott Laboratories

ABT 124.51

-1.7%

3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: HerbVic	8/11/2004 12:05:25 PM
	of 33

Abbott Laboratories "buy" Monday, August 09, 2004 2:00:59 PM ET Banc of America NEW YORK, August 9 (New Ratings) – Analyst Glenn J Novarro of Banc of America Securities issues a "buy" rating on Abbott Laboratories (ABT.NYS). The target price is set to $46. In a research note published this morning, the analyst mentions that the company is likely to witness consistent EPS growth of 10%-12% over the next three years. Banc of America Securities anticipates a limited impact of generic drug competition on Abbott Laboratories’ earnings during this period. newratings.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next